3D Cell Culture Market Trends 2013 Research & Survey Report

Jul 17, 2013, 10:30 ET from RnRMarketResearch

DALLAS, July 17, 2013 /PRNewswire/ --

RnRMarketResearch.com adds a 2013 survey report on three dimensional (3D) cell culture technologies that summarizes trends and results of HTStec's 3rd industry-wide global web-based benchmarking survey carried out in July 2013.

The main objectives of "3D Cell Culture Trends 2013" market study were to comprehensively document continuing interest in, experience gained and progress made in applying 3D cell culture technologies in academic research, drug discovery and tissue engineering/regenerative medicine settings, and to understand their future purchasing preferences. The main questionnaire consisted of 30 multi-choice questions and 2 open-ended questions. In addition, there were 5 questions related solely to the administration of survey. The survey collected 154 validated responses, of these 53% provided comprehensive input. Survey responses were geographically split: 46% Europe; 31% North America; 12% Asia (excluding Japan); 6% Japan; and 5% Rest of World.

As per the report "3D Cell Culture Trends 2013", the median budget allocated for spending on 3D cell culture consumables today (2013) was $10K-$25K. The biggest proportion of this budget was allocated to hydrogel 3D scaffolds. A bottom-up model was developed around the respondent's spending on 3D cell culture consumables to estimate the global market. In 2013 this market was estimated to be around $75M. Segmentation and CAGR estimates are given in the full report. Hydrogel 3D scaffolds (purchased separate of culture vessel) and microplates designed to encourage spheroid generation were the 3D consumables respondents were most interested in purchasing. BD Bioscience was the supplier of 3D cell culture consumables that first comes to the mind. The most purchased from 3D cell culture consumables suppliers were BD Bioscience, Corning and InSphero. Combined these 3 suppliers have around 50% market share. The median budget allocated for spending on 3D cell culture instruments today (2013) was <$5K. The full report provides the data, details of the breakdown of the responses for each question, its segmentation and the estimates for the future (2015). It also highlights some interesting differences between the survey groups, particularly Academic Research versus Drug Discovery or Tissue Engineering & Regenerative Medicine.

The report, available for purchase @ http://www.rnrmarketresearch.com/contacts/purchase?rname=106961, looked at the following aspects of 3D cell culture as practiced to date (2013) and in a few cases as predicted for the future (2015):

  • current level of adoption (% all cell culture wells processed) of 3D cell culture technologies
  • type of 3D structure most interest in generating in culture; main intended applications of 3D cell culture
  • approaches that have demonstrated most promise to date in facilitating 3D cell culture
  • vessel formats a 3D scaffold/matrix must have compatibility with
  • requirements for different types of 3D scaffold
  • different cell types used for 3D cell culture work
  • number of 3D wells per assay or project
  • total number of 3D wells per year
  • whether any high throughput (primary) screens using 3D technologies have been run to date
  • where 3D cell culture will make the biggest impact over the coming years
  • assay types successfully demonstrated using cells within a 3D matrix/structure
  • analytical technologies that have been applied to 3D cell culture today
  • how aspects of existing plate readers/imaging systems rate for use in the routine assay/detection/ interrogation of 3D cell culture derived structures
  • the most important tasks to automate in 3D cell culture
  • awareness of approaches/platforms used for the automation of 3D cell culture and tissue production/fabrication
  • interest in outsourcing 3D cell culture
  • interest in purchasing some assay-ready 3D constructs and outsourced 3D services
  • vendors that first comes to mind when you think of assay-ready 3D constructs and outsourced 3D services
  • interest in 3D organotypic microtissue models
  • level of success achieved with 3D cell culture
  • realistic adoption period for a new 3D scaffold
  • main barriers to the adoption of a new 3D matrix
  • whether 3D cell culture has reached its full market potential yet and what is still missing or where are the gaps/limitations in current 3D offerings
  • the relationship between spending on 3D consumable technologies versus other cell culture spending
  • budget for 3D cell culture consumables and its breakdown into components
  • 3D consumables most likely to be purchased in the future
  • suppliers of consumables and/or instruments that first come to mind and those most purchased from
  • budget allocation to purchase new equipment to enable 3D culture.

Respondents came from 83 University/Research Institute/Not-for-Profit Facilities; 21 Pharma; 15 Biotechs: 9 Other Organizations; 9 Hospitals/Clinics/Medical Schools; 5 Regen Med/Cell Therapy/Tissue Engineering Companies; 4 CROs; 3 Cosmetics Companies; 2 Government/Military/Defense Facilities; 2 Diagnostics Companies; and 1 Biomanufacturing/Bioprocessing Company.

Most survey respondents had a senior job role or position which was in descending order: 22 professors/ assistant professors; 19 research scientists; 18 principal investigators; 16 others; 16 senior scientists/researchers; 11 department heads; 11 lab managers; 10 directors; 9 graduate/PhD students; and 8 post-docs. Respondents represented labs with the following main activity: 37 cancer research; 31 basic research; 27 drug discovery; 13 tissue/organ engineering; 10 preclinical research/ADME/toxicology; 9 stem cell biology; 8 regenerative medicine; 6 other; 6 cell therapy; 5 clinical research; and 1 developmental biology.

Survey results were expressed as an average of all survey respondents. In addition, were appropriate the data was reanalyzed after sub-division into the following 5 survey groups: 1. Academic Research; 2. Drug Discovery; 3. Tissue Engineering & Regenerative Medicine; 4. Europe and 5. North America.

Comprehensive Table of Contents and complete report available at http://www.rnrmarketresearch.com/3d-cell-culture-trends-2013-market-report.html.

Explore more reports on the Cell Culture Market @ http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/cell-culture and Biotechnology Industry @ http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology.

About Us:

RnRMarketResearch.com (http://www.rnrmarketresearch.com/) is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Priyank Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
Explore More Industry Analysis Reports @ http://www.reportsnreports.com/.

SOURCE RnRMarketResearch